Search Results - "Satten, G A"

Refine Results
  1. 1

    Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection by Palella, Frank J, Delaney, Kathleen M, Moorman, Anne C, Loveless, Mark O, Fuhrer, Jack, Satten, Glen A, Aschman, Diane J, Holmberg, Scott D

    Published in The New England journal of medicine (26-03-1998)
    “…The treatment of human immunodeficiency virus (HIV) infection has undergone considerable change. 1 – 3 Protease inhibitors and non–nucleoside-analogue…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors by Busch, M P, Lee, L L, Satten, G A, Henrard, D R, Farzadegan, H, Nelson, K E, Read, S, Dodd, R Y, Petersen, L R

    Published in Transfusion (Philadelphia, Pa.) (01-02-1995)
    “…Almost all human immunodeficiency virus (HIV) transmission via blood or tissues that has occurred since anti-HIV screening was implemented in 1985 is traceable…”
    Get more information
    Journal Article
  4. 4

    Probability of female-to-male transmission of HIV-1 in Thailand by Mastro, T D, Satten, G A, Nopkesorn, T, Sangkharomya, S, Longini, Jr, I M

    Published in The Lancet (British edition) (22-01-1994)
    “…The epidemic of human immunodeficiency virus type 1 (HIV-1) infection in Thailand has allowed an estimate to be made of the probability of female-to-male HIV-1…”
    Get more information
    Journal Article
  5. 5

    Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States by Lackritz, Eve M, Satten, Glen A, Aberle-Grasse, John, Dodd, Roger Y, Raimondi, Vincent P, Janssen, Robert S, Lewis, W. Frank, Notari, Edward P, Petersen, Lyle R

    Published in The New England journal of medicine (28-12-1995)
    “…After the practice of screening all blood donations for antibodies to the human immunodeficiency virus (HIV) was introduced in the United States in 1985, the…”
    Get full text
    Journal Article
  6. 6

    HIV seroincidence and risk factors among patients repeatedly tested for HIV attending sexually transmitted disease clinics in the United States, 1991 to 1996 by WEINSTOCK, H, SWEENEY, S, SATTEN, G. A, GWINN, M

    “…To assess the incidence of HIV infection and risk factors associated with HIV seroconversion among patients attending clinics for sexually transmitted diseases…”
    Get full text
    Journal Article
  7. 7

    Late postnatal mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire by Ekpini, E R, Wiktor, S Z, Satten, G A, Adjorlolo-Johnson, G T, Sibailly, T S, Ou, C Y, Karon, J M, Brattegaard, K, Whitaker, J P, Gnaore, E, De Cock, K M, Greenberg, A E

    Published in The Lancet (British edition) (12-04-1997)
    “…HIV-1 can be transmitted from an infected mother to her infant through breastfeeding, although the precise risk of transmission by this route is unknown. A…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Accounting for Unmeasured Population Substructure in Case-Control Studies of Genetic Association Using a Novel Latent-Class Model by Satten, Glen A., Flanders, W.Dana, Yang, Quanhe

    Published in American journal of human genetics (01-02-2001)
    “…We propose a novel latent-class approach to detect and account for population stratification in a case-control study of association between a candidate gene…”
    Get full text
    Journal Article
  10. 10

    The incubation period to AIDS in injecting drug users estimated from prevalent cohort data, accounting for death prior to an AIDS diagnosis by HENDRIKS, J. C. M, SATTEN, G. A, VAN AMEIJDEN, E. J. C, VAN DRUTEN, H. A. M, COUTINHO, R. A, VAN GRIENSVEN, G. J. P

    Published in AIDS (London) (20-08-1998)
    “…To estimate the incubation-period distribution (time from seroconversion to AIDS) accounting for death before an AIDS diagnosis (DBAD) in a cohort of injecting…”
    Get full text
    Journal Article
  11. 11

    Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence by KOTHE, Denise, BYERS, Robert H, CAUDILL, Samuel P, SATTEN, Glen A, JANSSEN, Robert S, HANNON, W. Harry, MEI, Joanne V

    “…Less sensitive (LS) HIV-1 enzyme immunoassays (EIAs) have significantly improved the quantity and quality of HIV surveillance data. The first LS-HIV-1 EIA, the…”
    Get full text
    Journal Article
  12. 12

    Risk factors for HIV infection among abandoned Romanian children by Hersh, B S, Popovici, F, Jezek, Z, Satten, G A, Apetrei, R C, Beldescu, N, George, J R, Shapiro, C N, Gayle, H D, Heymann, D L

    Published in AIDS (London) (01-12-1993)
    “…To determine risk factors for HIV infection among abandoned Romanian infants and children living in a public institution. A cross-sectional study was conducted…”
    Get more information
    Journal Article
  13. 13

    Steady-state calculation of the risk of HIV infection from transfusion of screened blood from repeat donors by Satten, Glen A.

    Published in Mathematical biosciences (15-04-1997)
    “…All blood donations in the United States are screened for human immunodeficiency virus (HIV), the virus that causes AIDS; in spite of this, potentially…”
    Get full text
    Journal Article
  14. 14

    Repeat screening for HIV : When to test and why by KAPLAN, E. H, SATTEN, G. A

    “…This paper presents models for repeat HIV screening under conditions of constant low HIV incidence. The models reveal a direct link between the prevalence of…”
    Get full text
    Journal Article
  15. 15

    Use of immunological markers and continuous-time Markov models to estimate progression of HIV infection in homosexual men by Hendriks, J C, Satten, G A, Longini, I M, van Druten, H A, Schellekens, P T, Coutinho, R A, van Griensven, G J

    Published in AIDS (London) (01-06-1996)
    “…We used continuous-time Markov models based on CD4 cell counts and anti-CD3 reactivity (i.e., measure for T-cell quality) to study the progression of HIV…”
    Get more information
    Journal Article
  16. 16

    Simple methods for assessing haplotype-environment interactions in case-only and case-control studies by Kwee, L.C., Epstein, M.P., Manatunga, A.K., Duncan, R., Allen, A.S., Satten, G.A.

    Published in Genetic epidemiology (01-01-2007)
    “…For investigating haplotype‐environment interactions in case‐control studies, one can implement statistical methods based either on a retrospective likelihood…”
    Get full text
    Journal Article
  17. 17

    Direct oral questions to blood donors: the impact on screening for human immunodeficiency virus by Johnson, E S, Doll, L S, Satten, G A, Lenes, B, Shafer, A W, Kamel, H, Casanova, R J, Petersen, L R

    Published in Transfusion (Philadelphia, Pa.) (01-09-1994)
    “…In December 1990, the Food and Drug Administration recommended that all United States blood centers implement a policy of asking prospective donors direct oral…”
    Get more information
    Journal Article
  18. 18

    Informative Missingness in Genetic Association Studies: Case-Parent Designs by Allen, Andrew S., Rathouz, Paul J., Satten, Glen A.

    Published in American journal of human genetics (01-03-2003)
    “…We consider the effect of informative missingness on association tests that use parental genotypes as controls and that allow for missing parental data…”
    Get full text
    Journal Article
  19. 19

    Hold everything! Holding policies for protecting plasma supplies by Kaplan, Edward H., Satten, Glen A.

    Published in Mathematical biosciences (01-09-1999)
    “…In spite of advances in testing technologies for detecting infections such as human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus…”
    Get full text
    Journal Article
  20. 20

    Conditional Regression Analysis of the Exposure-Disease Odds Ratio Using Known Probability-of-Exposure Values by Satten, Glen A., Kupper, Lawrence L.

    Published in Biometrics (01-06-1993)
    “…Conditional inference methods are proposed for the odds ratio between binary exposure and disease variables when only the probability of exposure is known for…”
    Get full text
    Journal Article